Swedbank AB Boosts Position in Humana Inc. $HUM

Swedbank AB boosted its position in shares of Humana Inc. (NYSE:HUM) by 4.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 105,269 shares of the insurance provider’s stock after acquiring an additional 4,872 shares during the period. Swedbank AB owned 0.09% of Humana worth $27,388,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. Blue Trust Inc. boosted its stake in Humana by 3.6% during the second quarter. Blue Trust Inc. now owns 1,367 shares of the insurance provider’s stock valued at $334,000 after buying an additional 48 shares during the period. Atlas Brown Inc. raised its holdings in shares of Humana by 0.9% in the 2nd quarter. Atlas Brown Inc. now owns 6,369 shares of the insurance provider’s stock valued at $1,557,000 after acquiring an additional 54 shares in the last quarter. Ossiam boosted its position in shares of Humana by 1.6% during the 2nd quarter. Ossiam now owns 4,375 shares of the insurance provider’s stock valued at $1,070,000 after acquiring an additional 71 shares during the last quarter. Retirement Planning Co of New England Inc. grew its holdings in shares of Humana by 7.7% during the first quarter. Retirement Planning Co of New England Inc. now owns 1,040 shares of the insurance provider’s stock worth $275,000 after purchasing an additional 74 shares in the last quarter. Finally, Penserra Capital Management LLC grew its holdings in shares of Humana by 13.0% during the second quarter. Penserra Capital Management LLC now owns 662 shares of the insurance provider’s stock worth $161,000 after purchasing an additional 76 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on HUM shares. The Goldman Sachs Group cut their price target on shares of Humana from $235.00 to $215.00 and set a “sell” rating for the company in a research note on Monday, November 24th. Barclays cut their target price on shares of Humana from $245.00 to $234.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 25th. Truist Financial lowered their price target on Humana from $300.00 to $285.00 and set a “hold” rating on the stock in a research report on Monday, November 10th. Guggenheim reaffirmed a “buy” rating on shares of Humana in a research note on Friday, October 3rd. Finally, Evercore ISI began coverage on Humana in a research report on Monday, September 22nd. They set an “in-line” rating and a $295.00 price objective on the stock. Nine analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Humana presently has an average rating of “Hold” and an average price target of $294.32.

Humana Trading Up 0.6%

NYSE HUM opened at $258.78 on Friday. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $315.35. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68. The stock has a 50-day moving average of $258.90 and a 200-day moving average of $259.99. The firm has a market cap of $31.12 billion, a PE ratio of 24.25, a price-to-earnings-growth ratio of 1.52 and a beta of 0.46.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, beating the consensus estimate of $2.95 by $0.29. Humana had a return on equity of 12.86% and a net margin of 1.02%.The firm had revenue of $32.65 billion during the quarter, compared to the consensus estimate of $31.99 billion. During the same quarter in the previous year, the company posted $4.16 earnings per share. The business’s revenue was up 11.1% on a year-over-year basis. As a group, sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.4%. Humana’s dividend payout ratio (DPR) is presently 33.18%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.